BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11124057)

  • 41. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delivery of DNA to pulmonary endothelium using adenoviral vectors.
    Reynolds PN
    Methods Mol Biol; 2004; 246():69-89. PubMed ID: 14970586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell biology of pulmonary endothelium.
    Ryan US; Ryan JW
    Circulation; 1984 Nov; 70(5 Pt 2):III46-62. PubMed ID: 6091943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.
    Barcia C; Jimenez-Dalmaroni M; Kroeger KM; Puntel M; Rapaport AJ; Larocque D; King GD; Johnson SA; Liu C; Xiong W; Candolfi M; Mondkar S; Ng P; Palmer D; Castro MG; Lowenstein PR
    Mol Ther; 2007 Dec; 15(12):2154-63. PubMed ID: 17895861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retargeting adenoviral vectors to improve gene transfer into tumors.
    Hogg RT; Thorpe P; Gerard RD
    Cancer Gene Ther; 2011 Apr; 18(4):275-87. PubMed ID: 21183946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Redirecting adenovirus to pulmonary endothelium by cationic liposomes.
    Ma Z; Mi Z; Wilson A; Alber S; Robbins PD; Watkins S; Pitt B; Li S
    Gene Ther; 2002 Feb; 9(3):176-82. PubMed ID: 11859420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo transduction of photoreceptors or ciliary body by intravitreal injection of pseudotyped adenoviral vectors.
    Von Seggern DJ; Aguilar E; Kinder K; Fleck SK; Gonzalez Armas JC; Stevenson SC; Ghazal P; Nemerow GR; Friedlander M
    Mol Ther; 2003 Jan; 7(1):27-34. PubMed ID: 12573615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta.
    Xing A; Boileau P; Caüzac M; Challier JC; Girard J; Hauguel-de Mouzon S
    Hum Gene Ther; 2000 Jan; 11(1):167-77. PubMed ID: 10646648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
    Muzykantov VR; Atochina EN; Ischiropoulos H; Danilov SM; Fisher AB
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5213-8. PubMed ID: 8643555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector.
    Kim IH; Józkowicz A; Piedra PA; Oka K; Chan L
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13282-7. PubMed ID: 11687662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo biopanning: A methodological approach to identifying novel targeting ligands for delivery of biological agents to the vasculature.
    Work LM; Nicol CG; Denby L; Baker AH
    Methods Mol Med; 2005; 108():395-413. PubMed ID: 16028697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosis.
    McKay T; Reynolds P; Jezzard S; Curiel D; Coutelle C
    Mol Ther; 2002 Apr; 5(4):447-54. PubMed ID: 11945072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scavenger receptor A: a new route for adenovirus 5.
    Haisma HJ; Boesjes M; Beerens AM; van der Strate BW; Curiel DT; Plüddemann A; Gordon S; Bellu AR
    Mol Pharm; 2009; 6(2):366-74. PubMed ID: 19227971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted adenoviral vectors for cancer gene therapy (Review).
    Douglas J; Curiel D
    Int J Oncol; 1997 Aug; 11(2):341-8. PubMed ID: 21528220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metabolic function of the pulmonary endothelium: its clinical relevance.
    Junod AF
    Curr Probl Clin Biochem; 1983; 13():116-22. PubMed ID: 6317289
    [No Abstract]   [Full Text] [Related]  

  • 56. [Gene targeting].
    Tanpakushitsu Kakusan Koso; 1991 Oct; 36(13):2281-8. PubMed ID: 1745795
    [No Abstract]   [Full Text] [Related]  

  • 57. Targeting gene therapy vectors to the vascular endothelium.
    Work LM; Nicklin SA; Baker AH
    Curr Atheroscler Rep; 2003 May; 5(3):163-70. PubMed ID: 12667427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural bases for metabolic activity.
    Ryan US
    Annu Rev Physiol; 1982; 44():223-39. PubMed ID: 6280585
    [No Abstract]   [Full Text] [Related]  

  • 59. The endothelial cell surface.
    Ryan US; Ryan JW
    Biorheology; 1984; 21(1-2):39-56. PubMed ID: 6466796
    [No Abstract]   [Full Text] [Related]  

  • 60. In Vivo Noninvasive Imaging for Gene Therapy.
    Vassaux G; Groot-Wassink T
    J Biomed Biotechnol; 2003; 2003(2):92-101. PubMed ID: 12721514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.